Evidence map›Paper›PMID 41878626›Full record

ArticleInternational journal of general medicine2026

A Machine Learning Model for Predicting Recurrent Pregnancy Loss: Retrospective Integration of Routine Serum IL-33, C-Reactive Protein, and Lymphocyte Subset Counts.

Qiuxia Liu, Liyun Dong

Abstract read
In one paragraph

Article in International journal of general medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Qiuxia LiuDepartment of Obstetrics and Gynecology, XiDian Group Hospital, Xi'an, Shaanxi, People's Republic of China.
Liyun DongDepartment of Gynecology, Xi'an Traditional Chinese Medicine Hospital, Xi'an, Shaanxi, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Recurrent pregnancy loss (RPL), defined as two or more consecutive spontaneous miscarriages before 20 weeks of gestation, affects 2-5% of reproductive-age women globally, and current clinical predictors for it lack sufficient accuracy. This study aimed to construct a machine learning (ML) model for RPL prediction by integrating serum IL-33, C-reactive protein (CRP), and lymphocyte subset counts, and validate its performance in a retrospective cohort. Methods: A total of 340 reproductive-age women from XiDian Group Hospital and Xi'an Traditional Chinese Medicine Hospital (January 2020-December 2024) were enrolled. Baseline clinical characteristics, IL-33, CRP levels, and lymphocyte subset counts were collected as predictors, with RPL as the primary outcome. The dataset was split into a training set (70%) and a validation set (30%). Logistic regression, random forest, and XGBoost were trained with hyperparameter optimization via grid search, and model performance was evaluated by AUC, accuracy, sensitivity, specificity, PPV, and NPV. Results: Of the 340 participants, 85 (25.0%) had RPL and 255 (75.0%) did not. The RPL group had significantly lower IL-33 and CD4+/CD8+ ratio, higher CRP and NK cell proportions (all p < 0.001). XGBoost outperformed the other two models, with an AUC of 0.89 (95% CI: 0.82-0.96) in the training set and 0.85 (95% CI: 0.76-0.94) in the validation set; its validation set accuracy, sensitivity, specificity, PPV and NPV were 88.1%, 82.4%, 88.7%, 28.6% and 98.7%, respectively. Conclusion: The ML model integrating IL-33, CRP, and lymphocyte subset counts shows good discriminatory ability for RPL, providing a preliminary reference for identifying high-risk women in clinical practice.

Indexed as

C-reactive proteininterleukin-33lymphocyte subsetsmachine learningrecurrent pregnancy lossXGBoost

Identifiers

PMID41878626
PMCPMC13007681

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.